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Abstract
Background: Only a few large-scale studies have investigated the association between health-related quality of life
(HRQOL) and renal function. Moreover, the HRQOL of patients with moderate renal dysfunction is frequently
underestimated by healthcare providers. This study assessed the impact of renal function on preference-based
HRQOL in Korean adult population.
Methods: We analyzed data for 5,555 adults from the 3rd Korean National Health and Nutritional Examination Survey
2005. The EuroQol-5D (EQ-5D) utility score was used to evaluate HRQOL. The study subjects were stratified into three
groups based on their estimated glomerular filtration rates (eGFRs): ≥ 90.0, 60.0-89.9 and 30.0-59.9 mL/min/1.73 m2.
Individuals with advanced renal dysfunction were excluded from the analysis.
Results: The proportions of participants who reported problems in each of the five EQ-5D dimensions increased
significantly with decreasing eGFR. However, a significant decrease in the EQ-5D utility score was observed among
participants with an eGFR of 30.0-59.9 mL/min/1.73 m2. Participants with an eGFR of 30.0-59.9 mL/min/1.73 m2 had
an almost 1.5-fold higher risk of impaired health utility (the lowest quartile of EQ-5D utility score) compared with
those participants with eGFRs ≥ 90.0 mL/min/1.73 m2, after adjustment for age, gender, health-related behaviors,
socioeconomic and psychological variables, and other comorbidities. Among the five dimensions of the EQ-5D, an
eGFR of 30.0-59.9 mL/min/1.73 m2 was an independent determinant of self-reported problems in the mobility and
pain/discomfort dimensions.
Conclusions: Although age affects the association between renal dysfunction and the EQ-5D, moderate renal
dysfunction seems to be an important determinant of impaired health utility in a general population and may
affect the mobility and pain/discomfort dimensions of health utility.
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Background
Generic preference-based health-related quality of life
(HRQOL) instruments, which generate health state values
as a single numerical index, have been proposed for use in
health-economic analyses for comparing HRQOL across
different diseases and allocating proper healthcare
resources [1,2]. Because chronic kidney disease (CKD) is
highly interactive with various comorbidities including dia-
betes, cardiovascular and cerebrovascular diseases, the
substantial healthcare expenditure for patients with CKD
cannot be directly attributed to CKD itself [3]. Indeed, an
inadequate financial policy for pre-dialysis CKD is one of
the barriers preventing improved patients outcomes [4].
Thus, preference-based HRQOL measurement based on
renal function is needed for proper allocation of healthcare
resources to CKD patients.
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Although CKD is a progressive and life-long condition
with multiple medical comorbidities, its implications for
HRQOL have only been studied, for the most part, in the
advanced stages of CKD (stage 4-5) [5]. The HRQOL in
patients with advanced CKD is significantly impaired and
is an important indicator of future mortality [6]. More
recently, however, the high mortality rate and prevalence
of comorbid conditions even in patients in the earlier
stages of CKD [7] has raised concerns that HRQOL could
also be reduced in these patients. Indeed, there is consid-
erable evidence of decreased HRQOL among patients with
mild-to-moderate renal dysfunction compared with the
population with normal renal function [8-11]. However,
only limited information is currently available regarding
estimates of the relative impact of renal dysfunction on
HRQOL and predictors of HRQOL as targets of interven-
tion. Previous studies have demonstrated that various
comorbid conditions, such as anemia, hypertension, frailty,
symptom burden, and depression, negatively affect
HRQOL in pre-dialysis CKD patients [12]. However, these
studies have limited generalizability because they either
are based on a non-representative sample [9,13-16] or do
not allow for integration of HRQOL measures into health-
economic analyses because of the use of non-preference-
based models [11].
Therefore, a population-based study of the relationship
between renal function and preference-based health utility
measures may contribute to a comprehensive public
health strategy for the management of CKD. In the pre-
sent study, we analyzed population-based data from a
nationwide cross-sectional health survey to determine the




The data analyzed in this study were obtained from the 3rd
Korean National Health and Nutritional Examination Sur-
vey (KNHANES) 2005, which included a population-based
random sampling of 34,145 individuals in households
across 600 national districts. The survey was conducted
with a stratified, multi-stage, clustered probability design
in order to select a representative nationwide sample of
the non-institutionalized Korean population. A total of
28,590 subjects were excluded from this study because
they were age < 18 years (n = 8,292), did not complete
either the EQ-5D questionnaire (n = 9,720) or blood test
(n = 27,731), or had advanced renal dysfunction (n = 12).
After the above exclusion criteria were applied, 5,555 indi-
viduals aged 18 years or older who had an estimated glo-
merular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 were
included in this investigation. Because the analyzed survey
data are publicly available, ethical approval was not
required for this study.
Health-related quality of life
HRQOL was measured using the EuroQol-5D (EQ-5D)
questionnaire, a widely used generic preference-based
instrument [17,18]. The EQ-5D consists of five questions
regarding current health status in terms of mobility, self-
care, usual activities, pain or discomfort, and anxiety or
depression. Each question has three possible responses:
“no problems”, “some problems”, and “extreme problems”.
The EQ-5D health states are defined as a combination of
the responses for each item and the survey can therefore
yield 35 (= 243) possible combinations of responses. These
responses were converted into weighted values according
to the Korean value set [19], and the average was calcu-
lated as a quality adjustment weight for each health state.
The EQ-5D instrument has been translated into Korean,
and its validity (Spearman correlation coefficient with the
first question of the Health Survey Short-Form 36:-0.51 in
EQ-5D) and reliability (test-retest reliability) have been
demonstrated previously [19,20].
Laboratory parameters
Blood samples were collected after a 12-hour overnight
fast; they were properly processed, immediately refriger-
ated, and transported in cold storage to the central
laboratory (Seoul Medical Science Institute, Seoul,
Korea) within 24 hours. Serum creatinine, glucose, and
lipid levels were measured using the ADVIA 1650 sys-
tem (Bayer Health Care, Tarrytown, NY). The serum
creatinine concentration was measured using the kinetic
Jaffe method, and the inter-assay coefficient of variation
was less than 5%. Because the creatinine assay was not
calibrated to be traceable to an isotope dilution mass
spectrometry (IDMS), eGFR was calculated using the
original Modification of Diet in Renal Disease (MDRD)
equation as follows: eGFR = 186.3 × (serum creatinine)-
1.154 × (age)-0.203 × 0.742 (if female) [21]. Proteinuria
was measured by the urine dipstick test.
Demographic and clinical characteristics
Demographic characteristics included age, gender, marital
status (living with/without a spouse), education level (no
education or elementary school graduate/middle or high
school graduate/university graduate or higher), occupa-
tional status (white collar/blue collar/student, soldier or
housewife/no occupation), residential area (rural/urban),
and monthly individual income (lowest quartile/2nd and
3rd quartile/highest quartile) in US dollars. Individuals
who were legally married or cohabiting were considered to
have a spouse; single, divorced, or separated individuals
were categorized as not having a spouse. Information
about various comorbidities was also collected. Hyperten-
sion was identified in individuals who met at least one of
the following three criteria: physician diagnosis of hyper-
tension, self-report of antihypertensive drug intake, and
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systolic blood pressure (SBP) ≥ 140 mmHg or diastolic
blood pressure (DBP) ≥ 90 mmHg. Blood pressure was
measured manually twice at 30-second intervals after a
minimum of five minutes of rest in a seated position, and
the mean values were used to identify hypertensive partici-
pants. Diabetes was diagnosed in subjects with a fasting
plasma glucose ≥ 126 mg/dL or those patients who were
identified in the health interview survey as actively using
an oral hypoglycemic agent or insulin. Diagnosis of meta-
bolic syndrome was based on the presence of three or
more of the following: (1) waist circumference ≥ 90 cm for
men or ≥ 80 cm for women [22], (2) triglyceride levels ≥
150 mg/dL, (3) high-density lipoprotein cholesterol levels
< 40 mg/dL for men or < 50 mg/dL for women, (4) SBP ≥
130 mmHg or DBP ≥ 85 mmHg or self-report of antihy-
pertensive drug therapy, and (5) fasting plasma glucose
level ≥ 100 mg/dL or self-report of ongoing treatment
with an oral hypoglycemic agent or insulin. Anemia was
defined as a hemoglobin level of < 13 g/dL for men and <
12 g/dL for women. Information regarding ischemic heart
disease and cerebrovascular accidents was acquired from
self-reported history. Ischemic heart disease included
angina pectoris and myocardial infarction. Proteinuria was
categorized into 3 groups according to the degree of pro-
teinuria measured by the dipstick as negative, mild (trace
to 1+), or heavy (2+ to 4+).
Information on health-related behaviors such as smok-
ing status (life-time smoker/non-smoker), alcohol intake
(less than once per month/more than once per month),
and regular physical activity of moderate intensity (more/
less than three times per week) was obtained from the
health questionnaire. Life-time smokers included those
adults who reported that they had smoked at least 100
cigarettes in their lifetime, and non-smokers included
respondents who had smoked fewer than 100 cigarettes in
their lifetime and did not smoke at the time of the survey.
Moderate-intensity activities were defined as those lasting
at least 10 minutes and causing a slight increase in the
individual’s heart rate compared with sedentary activities;
table tennis, swimming, yoga and badminton were
included as moderate-intensity activities, but walking was
excluded. Psychological variables from questionnaires
included self-reported stress (none or small amount/some
or extreme) and sleep quality (sufficient/insufficient).
Statistical analysis
Data are presented as frequencies and percentages for
categorical variables. Continuous variables are reported as
means with standard deviations. Estimated GFR values
were stratified into three categories (≥ 90.0, 60.0-89.9, and
30.0-59.9 mL/min/1.73 m2). Differences in demographic,
socioeconomic, and psychological factors, as well as in
health-related behavioral patterns and the EQ-5D utility
scores across the eGFR categories were compared using
the c2 test for trends (linear-by-linear association) for cate-
gorical variables. Similarly, a one-way analysis of variance
was used to demonstrate the linearity of continuous vari-
ables across eGFR categories.
Univariate logistic regression analysis was performed to
assess the relationship between impaired health utility
(EQ-5D index score in lowest quartile) [23] and clinical or
demographic data. Variables that showed significant asso-
ciation in the univariate analysis or that were of consider-
able theoretical relevance were entered into the
multivariate logistic regression analysis using the backward
conditional elimination method. To analyze the determi-
nants of problems in each of the five EQ-5D dimensions,
the three possible responses were dichotomized as “no
problem” or “any problem”, and a multivariate logistic
regression analysis was performed with the presence of
“any problem” as the dependent variable. Covariables that
had co-linearity were excluded from the multivariate ana-
lyses. An analysis of covariance (ANCOVA) with the
Bonferroni correction was used to estimate age-adjusted
distributions of the EQ-5D utility score according to
serum eGFR. All analyses were conducted using SPSS soft-
ware (version 19.0, SPSS, IL), and P < 0.05 was considered
to indicate statistical significance.
Results
Characteristics of the study population
The demographic characteristics of the participants, strati-
fied by eGFR, are shown in Table 1. The mean age of the
study subjects was 46.5 ± 15.7 years, and 42.8% were male.
A total of 716 participants had an eGFR of ≥ 90.0 mL/min/
1.73 m2, 4,353 had an eGFR of 60.0-89.9 mL/min/1.73 m2,
and 486 had an eGFR of 30.0-59.9 mL/min/1.73 m2. The
mean eGFR of each group was as follows: 96.7 mL/min/
1.73 m2 in the group with eGFRs of ≥ 90.0 mL/min/1.73
m2; 75.3 mL/min/1.73 m2 in the group with eGFRs of
60.0-89.9 mL/min/1.73 m2, and 55.9 mL/min/1.73 m2 in
the group with eGFRs of 30.0-59.9 mL/min/1.73 m2. Sub-
jects with a lower eGFR were older, predominantly
women, and more likely to have comorbidities, including
diabetes, hypertension, metabolic syndrome, anemia,
ischemic heart disease and cerebrovascular accidents.
Table 2 shows the variables associated with health-
related behaviors, socioeconomic status, and psychologi-
cal variables. Subjects with a lower eGFR showed better
health-related behavioral patterns, including lower rates
of smoking and alcohol consumption. On the other hand,
the proportion of subjects living in a rural area, having no
occupation, or with less education was significantly
higher as the eGFR decreased. In addition, household
income also decreased with decreasing eGFR. Although
the degree of stress did not differ between eGFR groups,
the proportion of participants experiencing poor sleep
quality increased significantly with decreasing eGFR and
Lee et al. BMC Nephrology 2012, 13:19
http://www.biomedcentral.com/1471-2369/13/19
Page 3 of 11
was particularly low in the group with eGFRs of 30.0-59.9
mL/min/1.73 m2.
HRQOL: EQ-5D dimensions and health utility score
The proportions of participants reporting problems (some
problem/extreme problem) in each dimension of the EQ-
5D questionnaire are shown in Figure 1. There was a
significant increase in reported problems in all dimensions
of the EQ-5D with decreasing eGFR. In total, 46.1% of par-
ticipants with eGFRs of 30.0-59.9 mL/min/1.73 m2 had
problems with mobility, 9.6% had problems with self-care,
32.6% had problems with usual activity, 70.5% had pro-
blems with pain/discomfort, and 37.8% had problems with
anxiety/depression.











Age 46.5 ± 15.7 32.3 ± 12.1 46.5 ± 14.0 67.7 ± 9.9 < 0.001
Male 2,379 (100) 456 (19.2) 1,835 (77.1) 88 (3.7)
Female 3,176 (100) 260 (8.2) 2,518 (79.3) 398 (12.5)
eGFR 76.4 ± 12.2 96.7 ± 5.6 75.3 ± 8.2 55.9 ± 5.5 < 0.001
Proteinuria (%) 0.141
Negative 94.4 93.3 94.9 91.6
Mild 4.8 5.9 4.5 6.1
Heavy 0.8 0.7 0.6 2.3
Co-morbidities (%)
Diabetes mellitus 7.6 3.7 7.0 19.0 < 0.001
Hypertension 25.3 11.0 24.1 55.3 < 0.001
Metabolic syndrome 29.4 13.8 28.4 60.0 < 0.001
Anemia 11.2 9.5 11.0 16.0 0.001
Ischemic heart disease 2.2 0.4 2.0 6.0 < 0.001
Cerebrovascular disease 2.2 0.5 1.8 8.2 < 0.001
Data are expressed as the mean ± standard deviation or a percentage. eGFR calculated using the modified MDRD formula [21]. Ischemic heart disease included
angina pectoris and myocardial infarction. eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease.












Marital status: living without a spouse (%) 28.5 48.6 23.2 46.8 0.001
Occupation (%) < 0.001
White collar 31.9 34.2 34.0 9.5
Blue collar 26.6 26.1 27.1 22.1
Student/soldier/housewife 25.9 30.2 25.2 26.1
No occupation 15.6 9.5 13.6 42.0
Education (%) < 0.001
University or higher 25.3 33.1 26.2 4.9
Upper secondary level 49.9 58.8 51.6 21.4
Compulsory education 24.9 8.1 22.2 73.8
Income (US $) 2,090.9 ± 1,489.0 2,221.5 ± 1,326.5 2,166.5 ± 1,509.5 1,298.9 ± 1280.8 < 0.001
Rural residence (%) 22.7 19.0 21.9 35.4 < 0.001
Some or extreme degree of stress (%) 33.9 33.4 33.8 33.6 0.778
Sleep quality: insufficient sleep (%) 35.6 41.1 35.5 29.0 < 0.001
Physical activity: ≤ 3 times per week (%) 13.4 16.2 13.5 5.8 0.145
Smoking: life-time smoker (%) 37.9 46.2 37.9 26.0 < 0.001
Alcohol intake: ≥ once a month (%) 31.2 39.5 32.1 11.6 < 0.001
Data expressed a as a percentage or the mean ± standard deviation. eGFR was calculated using the modified MDRD formula [21]. Upper secondary level of
education included middle and high school graduate. Compulsory education meant elementary school graduate or less. eGFR, estimated glomerular filtration
rate; MDRD, Modification of Diet in Renal Disease.
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The crude EQ-5D utility score significantly decreased
with decreasing eGFR (Figure 2A). The mean age-
adjusted EQ-5D utility score for all participants was
0.845 ± 0.004 (standard error of the mean). The age-
adjusted EQ-5D utility score was significantly lower
among participants with an eGFR of 30.0-59.9 mL/min/
1.73 m2 (0.807 ± 0.009) compared with those participants
with an eGFR of ≥ 90.0 mL/min/1.73 m2 (0.857 ± 0.003)
or 60.0-89.9 mL/min/1.73 m2 (0.870 ± 0.003) (Figure 2B).
Figure 3 shows data from a nationally representative cat-
alogue of age-adjusted mean EQ-5D utility scores for
major chronic diseases, as derived from data from the 3rd
KNHANES [24]. When our results were integrated with
the data from that catalogue, we found that individuals
with an eGFR of 30.0-59.9 mL/min/1.73 m2 had lower uti-
lity scores than those individuals with chronic obstructive
pulmonary disease, asthma, hypertension, or diabetes.
Correlates of impaired health utility
A logistic regression model was built to assess factors
that were significantly associated with impaired health
utility, defined as an EQ-5D utility score in the lowest
quartile. To perform logistic regression analysis, certain
continuous values were transformed into categorical
values, as previously described. Subjects were divided
into three age groups, as follows: < 40 years old, 40-60
years old, and ≥ 60 years old. Body mass index and lipid
levels were considered as components of metabolic syn-
drome. Table 3 displays the results of univariate and mul-
tivariate analyses for impaired HRQOL. In the univariate
regression analysis, variables including age, gender,
health-related behaviors (smoking, alcohol intake), socio-
economic factors (marital status, area of residence, occu-
pation, education, and household income), psychological
factors (stress, sleep quality), and other co-morbidities
(e.g., hypertension, diabetes, metabolic syndrome,
ischemic heart disease and cerebrovascular disease)
showed significant association with impaired health uti-
lity. However, the degree of proteinuria failed to prove its
association with health utility in the univariate regression
analysis.
In the multivariate analysis, an eGFR of 30.0-59.9 mL/
min/1.73 m2 was one of the independent risk factors pre-
dicting impaired health utility (odds ratio (OR) 1.531; 95%
confidence interval (CI) 1.077-2.176; P = 0.018) after
adjustment for age, sex, comorbidities (diabetes, hyperten-
sion, metabolic syndrome, ischemic heart disease, and cer-
ebrovascular accidents) health-related behaviors (alcohol
intake, smoking, and physical activity), socioeconomic fac-
tors (marital status, occupation, education, rural residence,
and income) and psychological factors (stress and sleep
quality).
In the binary multivariate logistic regression on EQ-5D
responses, an eGFR of 30.0-59.9 mL/min/1.73 m2 was
Figure 1 Proportion of participants who reported problems in each of the five EQ-5D dimensions.
Lee et al. BMC Nephrology 2012, 13:19
http://www.biomedcentral.com/1471-2369/13/19
Page 5 of 11
significantly associated with reported problems in the
mobility (OR, 2.192; 95% CI, 1.178-4.077; P = 0.013) and
pain/discomfort dimensions (OR, 1.574; 95% CI, 1.113-
2.225; P = 0.010). Although impaired renal function was
significantly associated with the self-care, usual activities,
and anxiety/depression dimensions in the univariate ana-
lyses, these associations lost statistical significance after
adjustment for covariates (Table 4).
Discussion
This is the first population-based analysis of the impact
of renal dysfunction on preference-based health utility
using a generic preference-based instrument. In this
cross-sectional study, we found that moderate renal dys-
function is independently associated with reduced health
utility, particularly in the domains of mobility and pain/
discomfort.
Until recently, increasing comorbidities, along with the
progression of CKD, was thought to play an important
role in reduced HRQOL in patients with renal dysfunc-
tion [12]. There are, however, conflicting data on the
association between HRQOL and renal function itself,
especially among patients with mild-to-moderate renal
dysfunction. In the Renal Research Institute-CKD study
[25], eGFR had no linear association with HRQOL, and
low eGFR was not an independent determinant of
reduced HRQOL. Similarly, Odden et al. [9] found that
age-adjusted HRQOL is significantly associated with
renal dysfunction but that the effect is attenuated by
demographic and socioeconomic variables. However,
these studies were performed using subjects who had
either profound renal dysfunction [25] or a history of
cardiovascular events [9], both of which are major con-
founders in a HRQOL analysis. Therefore, these data
may not be applicable to population with mild-to-mod-
erate renal dysfunction. On the contrary, Chin et al.
[14] reported that an eGFR value of 45 mL/min/1.73 m2
or lower is an independent determinant of impaired
HRQOL in the elderly Korean population. Similarly, in a
population-based study in Australia, Chow et al. [11]
reported that an eGFR lower than 60 mL/min/1.73 m2
is significantly associated with an impaired HRQOL
after adjusting for comorbidities associated with CKD.
In accordance with previous population-based studies,
we also demonstrated that an eGFR of 30.0-59.9 mL/
min/1.73 m2 remains an independent predictor of
impaired HRQOL after adjustment for demographic,
socioeconomic and psychological factors, and major
comorbidities associated with CKD. We hypothesize
that the conflicting findings regarding the impact of
renal function on preference based health utility are lar-
gely due to the differences in study subjects in terms of
their renal function and comorbidities. Because the
number and severity of comorbidities increase with the
Figure 2 Mean values of the EQ-5D utility score in a Korean adult population without adjustment (A) and adjusted for age (B). Error
bars indicate the standard error of the mean.
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progression of CKD, it can be assumed that GFR is a
more important determinant of health utility in mild-to-
moderate renal dysfunction. Thus, early detection of
renal dysfunction and proper therapeutic intervention
are important to public health efforts aimed at improv-
ing health utility.
In this study, the dimensions of EQ-5D that were par-
ticularly affected by moderate renal dysfunction were
mobility and pain/discomfort, suggesting that these two
components are responsible for the reduction in health
utility scores that is associated with declining renal func-
tion. Although physical inactivity or functional limita-
tions are frequently observed even in patients with mild-
to-moderate renal dysfunction and are also a modifiable
risk factor for mortality [26-29], there are conflicting
data regarding the impact of renal function on physical
activity in these patients. Data from a community-based
survey of the US adult population showed that impair-
ment in physical function among CKD patients is
related to comorbidities and old age rather than to renal
function itself [26]. However, other reports have sug-
gested that renal dysfunction is directly associated with
impaired physical function in elderly persons, indepen-
dent of comorbidities [14,30]. Similarly, the prevalence
of frailty, of which loss of mobility is a key component,
increases with decreasing renal function in elderly
cohorts, independent of comorbidities. Although the
reasons for the association are unclear, unmeasured
confounding variables such as sarcopenia [31], inflam-
mation [32], malnutrition, or other co-morbidities may
play a role [12].
In addition to impaired mobility, we found that more
than 70% of the participants with an eGFR of 30.0-59.9
mL/min/1.73 m2 reported that they had some or
extreme pain or discomfort, and an eGFR of 30-59.9
mL/min/1.73 m2 remained an independent risk factor
for self-reported problems in the pain/discomfort
dimension after adjusting for covariates. Similarly, the
Renal Research Institute-CKD study showed that the
presence of physical pain among patients with CKD
Figure 3 EQ-5D utility scores for chronic diseases in Korea [24]. The black bar indicates patients with eGFR 30.0-59.9 mL/min/1.73 m2 who
were investigated in this study.
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stages 3-5 was associated with lower HRQOL [25].
Unfortunately, chronic pain is often not only unrecog-
nized, but also inadequately treated in the CKD popula-
tion [33]. Therefore, regular screening for pain and the
development of safe and effective treatments for chronic
pain are necessary to improve HRQOL in the CKD
population.
The EQ-5D is a useful preference-based measurement of
HRQOL that incorporates values or utilities for health
status and can be used in health-economic analyses to
optimize resource allocation [34,35]. In this study, we
found that age-adjusted EQ-5D utility scores in partici-
pants with moderate renal dysfunction are lower than in
patients with diabetes, hypertension, asthma or chronic
obstructive pulmonary disease. Despite the substantially
lower health utility of these patients and the chronicity of
the disease, CKD awareness is extremely low in both high-
and low-income countries [36]. Indeed, the awareness rate
Table 3 Univariate and multivariate logistic regression analyses for impaired HRQOL
Univariate analysis Multivariate analysis
Unadjusted OR (95% CI) P Adjusted OR (95% CI) P
Age (year) < 40 Reference Reference
40-60 2.205 (1.910-2.545) < 0.001 1.598 (1.345-1.879) < 0.001
≥ 60 9.573 (8.117-11.289) < 0.001 3.337 (2.598-4.287) < 0.001
Male Male 0.569 (0.508-0.638) < 0.001 0.569 (0.487-0.666) < 0.001
eGFR ≥ 90.0 Reference Reference
60.0-89.9 1.994 (1.639-2.426) < 0.001 1.168 (0.929-1.469) 0.185
30.0-59.9 10.372 (7.868-13.672) < 0.001 1.531 (1.077-2.176) 0.018
Diabetes mellitus Yes 2.140 (1.747-2.622) < 0.001
Hypertension Yes 2.554 (2.252-2.895) < 0.001 1.231 (1.048-1.445) 0.011
Metabolic syndrome Yes 2.091 (1.853-2.358) < 0.001
Ischemic heart disease Yes 8.419 (5.184-13.675) < 0.001 3.730 (2.169-6.415) < 0.001
Cerebrovascular accident yes 3.349 (3.505-8.164) < 0.001 1.971 (1.194-3.256) 0.008
Alcohol intake ≥ 1/week 0.652 (0.576-0.737) < 0.001
Smoking status life-time smoker 0.789 (0.703-0.886) < 0.001
Marital status without spouse 1.290 (1.141-1.458) < 0.001
Occupation white collar Reference Reference
blue collar 2.545 (2.184-2.965) < 0.001 1.400 (1.154-1.689) 0.001
other† 1.944 (1.661-2.275 < 0.001 1.328 (1.097-1.608) 0.004
no occupation 4.953 (4.148-5.914) < 0.001 1.741 (1.378-2.199) < 0.001
Education ≥ university Reference Reference
upper 2ndary‡ 1.886 (1.608-2.213) < 0.001 1.294 (1.076-1.555) 0.006
≤ compulsory§ 9.607 (8.035-11.488) <0.001 2.515 (1.970-3.212) < 0.001
Income highest quartile Reference Reference
2nd -3rd quartile 1.432 (1.224-1.674) < 0.001 1.139 (0.953-1.360) 0.152
lowest quartile 4.735 (3.986-5.625) < 0.001 1.676 (1.356-2.072) < 0.001
Residence rural residence 2.056 (1.808-2.339) < 0.001 1.190 (1.011-1.401) 0.036
Stress some or extreme 1.752 (1.559-1.968) < 0.001 1.753 (1.525-2.016) < 0.001
Sleep quality insufficient 1.276 (1.137-1.432) < 0.001 1.606 (1.396-1.848) < 0.001
Values shown are OR (95% CI). Impaired HRQOL was defined as the lowest quartile of EQ-5D weighted values. Potential risk factors in the unadjusted analysis
(P < 0.05) were included in the adjusted analysis. The multivariate logistic regression analysis model was derived using the backward conditional method.
†Students, soldiers and housewives; ‡middle and high school graduates; §elementary school or no education. HRQOL, health-related quality of life; eGFR,
estimated glomerular filtration rate (mL/min/1.73 m2); OR, odds ratio; CI; confidence interval
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of CKD (stage I to III) has been reported to be lower than
10%, whereas the awareness rates of diabetes and hyper-
tension are 55.8% and 51% respectively in Korea [37].
Moreover, the World Health Organization (WHO) does
not yet recognize CKD as a major chronic disease that
must be prevented to reduce mortality. Even though it
seems apparent that early CKD detection and proper
intervention can vastly reduce healthcare expenses for
end-stage renal disease, these preventive strategies are
implemented less frequently than recommended, even in
developed countries. In addition, according to the budget
expenditure report of the Centers for Disease Control and
Prevention, CKD was allotted the smallest budget consid-
ering the burden of the disease [38]. Taken together, these
findings suggest that healthcare resource allocation for
CKD is inadequate. Under such circumstances, the results
of this study provide evidence that moderate renal dys-
function may be worthy of a proportionate allotment of
the available healthcare resources.
This cross-sectional study has several limitations that
needed to be addressed. First, the present data showed
skewed distributions of gender and eGFR groups. In this
study, the proportion of the subjects in the normal renal
function (eGFR ≥ 90.0 mL/min/1.73 m2) group was lower
than that of the mildly decreased renal function group
(eGFR 60.0-89.9 mL/min/1.73 m2). In addition, the pro-
portion of women was higher compared with men, espe-
cially in the stage III CKD group compared with other
population-based studies [39]. Although these deviant
distributions may be partly explained by the inaccuracy
of the MDRD equations in Asian populations [40], and
an incorrect coefficient factor for female gender, which
Table 4 Binary multivariate logistic regression of the EQ-5D dimensions
EQ-5D dimensions
Mobility Self-care Usual activity Pain/discomfort Anxiety/depression
Age < 40 Reference Reference Reference Reference Reference
40-60 2.796 (1.196-4.354)# 9.205 (2.148-39.441)** 3.137 (1.986-4.955)# 1.601 (1.347-1.903)# 1.347 (1.118-1.623)**
≥ 60 7.230 (4.462-11.716)# 13.686 (3.095-60.511)** 5.788 (3.529-9.494)# 3.254 (2.537-4.174)# 1.603 (1.243-2.068)**
Sex male 0.452 (0.354-0.578)# - 0.565 (0.440-0.727)** 0.543 (0.464-0.635)# 0.461 (0.364-0.584)#
eGFR ≥ 90.0 Reference – – Reference –
60.0-89.9 1.863 (1.053-3.296)* 1.240 (0.982-1.565)
30.0-59.9 2.192 (1.178-4.077)* 1.574 (1.113-2.225)*
Diabetes mellitus – – – – –
Hypertension 1.412 (1.419-1.735)* – – 1.225 (1.045-1.435)* –
Metabolic syndrome – – – – –
Ischemic heart disease 2.403 (1.523-3.791)# – 1.968 (1.245-3.110)** 2.515 (1.558-4.058)# 1.987 (1.316-2.999)**
Cerebrovascular disease 3.056 (1.886-4.953)# 5.326 (3.091-9.179)# 3.018 (1.907-4.777)# 1.578 (0.987-2.524) 1.833 (1.188-2.827)**
Anemia – – 1.385 (1.029-1.864) * - -
Alcohol intake – 0.518 (0.306-0.877)* – – –
Smoking – - - – 1.329 (1.060-1.667)*
Physical inactivity 1.246 (0.978-1.589) 1.978 (1.098-3.564)* 1.435 (1.098-1.875)** - 1.158 (0.978-1.372)
Marital status without spouse – – – – –
Occupation white collar Reference Reference Reference Reference Reference
blue collar 1.401 (0.987-1.988) 0.935 (0.436-2.005) 1.336 (0.920-1.939) 1.540 (1.272-1.863)# 1.194 (0.960-1.486)
other† 1.403 (0.985-1.998) 1.318 (0.619-2.808) 1.355 (0.926-1.983) 1.342 (1.108-1.625)** 1.213 (0.981-1.499)
no occupation 2.293 (1.600-3.287)# 2.369 (1.146-4.898)* 2.148 (1.464-3.149)# 1.637 (1.298-2.065)# 1.581 (1.234-2.026)**
Education ≥ university Reference Reference Reference Reference Reference
upper 2ndary‡ 1.976 (1.226-3.187)** 1.830 (0.618-5.423) 1.680 (1.026-2.751)* 1.235 (1.027-1.486)* 1.276 (1.032-1.578)*
≤ compulsory§ 4.347 (2.631-7.181)# 3.468 (1.154-10.421)* 3.221 (1.907-5.440)# 2.306 (1.810-2.938)# 1.697 (1.286-2.240)#
Income highest quartile Reference Reference Reference Reference Reference
2nd -3rd quartile 1.215 (0.857-1.722) 1.534 (0.662-3.554) 1.563 (1.048-2.332)* 1.121 (0.938-1.339) 1.209 (0.983-1.488)
lowest quartile 1.941 (1.367-2.758)# 3.005 (1.324-6.825)** 2.442 (1.632-3.654)# 1.590 (1.288-1.963)# 1.879 (1.483-2.381)#
Residence rural 1.383 (1.107-1.727)** – 1.581 (1.255-1.992)# - 0.854 (0.714-1.021)
Stress some/extreme 1.455 (1.186-1.785)# - 1.496 (1.208-1.852)# 1.739 (1.514-1.997)# 3.041 (2.633-3.513)#
Sleep quality insufficient - - - 1.613 (1.403-1.854)# -
Values shown are OR (95% CI). Cells with a dash indicate that the variable was not included in the model. Cells with two dashes indicate that the variable was
included in the multivariate model but excluded after the multivariate analysis. The multivariate logistic regression analysis model was derived using the
backward conditional method. † Students, soldiers and housewives; ‡ middle and high school graduates; § elementary school or no education; *P < 0.05;
**P < 0.001; #P < 0.001. eGFR, estimated glomerular filtration rate (mL/min/1.73 m2); OR, odd ratio; CI, confidence interval
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underestimates true GFR [41], the possibility of potential
selection bias cannot be ruled out in this study. Second,
the possible confounding effect of age which is strongly
associated with both CKD and health utility could also
affect the results. Furthermore, the associations we
observed were only inferred from this analysis, and
unmeasured residual confounding should be considered
in when interpreting our results. Third, the method for
serum creatinine measurement was not calibrated to be
traceable to IDMS. Thus, there is the possibility of
under-estimating the GFR in participants with GFR over
60 mL/min/1.73 m2 [42]. Finally, no longitudinal data
were available on the associations between health utility
and mortality or progression to end stage renal disease
among CKD participants. The precise
reason why renal impairment contributes to decreased
health utility was not investigated in this cross-sectional
analysis, and the interventions that could positively
affect CKD patients’ health utility remain unknown.
Conclusions
In this study, moderate renal dysfunction was indepen-
dently associated with impaired health utility in a Korean
adult population, even though age had substantial influ-
ence on the association. Reduced mobility and increased
pain or discomfort were the two dimensions significantly
that were affected by moderate renal dysfunction. In
addition, subjects with moderate renal dysfunction
showed lower age-adjusted health preference scores than
those subjects with major chronic diseases including dia-
betes and hypertension. These results indicate that more
careful assessment of preference-based utility and proper
healthcare resource allocation are required for patients
with moderate renal dysfunction to improve clinical
outcomes.
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